Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Naples
Clinical trial register · Italy

Clinical Trials in Naples, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 36 Roma 25 Naples 18 Bologna 12 Genova 12
Narrow the registerReset
Recruitment status
Phase
Site location
Milan36 Roma25 Naples18 Bologna12 Genova12
All 61 locations
Target enrolment
to

Trials with a site in Naples

18 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
GlaxoSmithKline
Phase 2
363
Milan, Naples, Roma
2025-10-30
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
GlaxoSmithKline
Phase 1/2
83
Bologna, Naples
2025-03-06
Recruiting
GlaxoSmithKline
Phase 1/2
305
Milan, Roma, Naples
2025-03-04
Active, closed
GlaxoSmithKline
Phase 2
283
Bergamo, Florence, Milan, Naples, Padova, Pisa, Roma
2024-11-11
Recruiting
GlaxoSmithKline
Phase 1
845
Milan, Naples, Roma, Verona
2024-09-30
Active, closed
GlaxoSmithKline
Phase 2
153
Genova, Milan, Naples, Roma, Sassari
2024-09-17
Recruiting
GlaxoSmithKline
Phase 3
440
Ancona, Milan, Modena, Naples, Padova, Palermo, Pavia, Pisa
2024-09-11
Active, closed
GlaxoSmithKline
Phase 3
10,212
Negrar, Alessandria, Bari, Belluno, Ferrara, Naples, Palermo, Pessione - Chieri to
2024-08-01
Recruiting
GlaxoSmithKline
Phase 3
864
Bolzano, Bologna, Milan, Naples, Pavia, Prato, Roma, Rozzano MI
2024-03-21
Active, closed
GlaxoSmithKline
Phase 4
336
Genova, Monserrato CA, Naples, Pieve Di Soligo TV, Roma, Rozzano, Verona
2024-03-20
Active, closed
GlaxoSmithKline
Phase 2
316
Rozzano, Bari, Bologna, Florence, Genova, Milan, Naples, Novara
2023-11-14
Recruiting
GlaxoSmithKline
Phase 3
892
Cagliari, Genova, Milan, Naples, Padova, Pisa, Reggio Emilia, Roma
2023-08-01
Recruiting
GlaxoSmithKline
Phase 3
109
Bologna, Catania, Milan, Naples, Novara, Pavia, Roma, Treviso
2022-09-06
Active, closed
GlaxoSmithKline
Phase 2
360
Bergamo, Milan, Modena, Naples, Palermo, Pisa
2021-12-14
Active, closed
GlaxoSmithKline
Phase 2/3
758
Ancona, Avellino, Florence, Milan, Monza, Naples, Orbassano to, Perugia
2020-12-08
Active, closed
GlaxoSmithKline
Phase 3
242
Milan, Modena, Monza, Naples, Negrar Verona, Padova, Palermo, Roma
2020-07-14
Active, closed
Extended Access of Momelotinib in Adults With Myelofibrosis
NCT03441113Neoplasms, Post-polycythemia Vera Myelofibrosis (Post-PV MF), Primary Myelofibrosis (PMF), Post-essential Thrombocythemia Myelofibrosis (Post-ET MF)
GlaxoSmithKline
Phase 2
237
Bologna, Florence, Genova, Milan, Monza, Naples, Pesaro, Rionero in Vulture PZ
2018-05-03
Rows per page Showing 1–18 of 18
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 13 October 2026. https://priyalifescience.com/clinical-trials-italy/city/naples

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 18 of those studies with a site in Naples that also match the filters currently applied.

How many clinical trials are recruiting in Naples?

8 of the 18 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 10 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Naples), 18 studies
PhaseStudiesRecruitingShare
Phase 26133.3%
Phase 36433.3%
Phase 12211.1%
Phase 1/22111.1%
Phase 2/3105.6%
Phase 4105.6%

Most active sponsors

Lead sponsors with the most studies (Naples)
Lead sponsorStudiesRecruiting
GlaxoSmithKline188
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.